Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H15BrN2O3 |
| Molecular Weight | 279.131 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(Br)(CC)C(=O)NC(=O)NC(C)=O
InChI
InChIKey=SAZUGELZHZOXHB-UHFFFAOYSA-N
InChI=1S/C9H15BrN2O3/c1-4-9(10,5-2)7(14)12-8(15)11-6(3)13/h4-5H2,1-3H3,(H2,11,12,13,14,15)
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10081103
Oral medication of 100 mg acecarbromal, 30 mg extract of cortex quebracho and 33 mg tocopherol acetate (Afrodor) in 100 patients complaining secondary erectile dysfunction. The patients were treated unselected with 3 x 1 tablet/day during the diagnostic schedule.
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ACECARBROMAL
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
77-66-7
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
1549
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104673
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
100000087907
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
42
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
16688
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | RxNorm | ||
|
6489
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
201-047-1
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
E47C56IGOY
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
C76932
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
m1292
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID9058810
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY | |||
|
SUB05198MIG
Created by
admin on Mon Mar 31 18:13:13 GMT 2025 , Edited by admin on Mon Mar 31 18:13:13 GMT 2025
|
PRIMARY |
ACTIVE MOIETY